Sulforaphane, Nrf2, and Healthy Aging Research

Summarize human and mechanistic research related to sulforaphane and healthy aging. Focus on Nrf2, glutathione, antioxidant response, cellular defense, detoxification enzymes, and oxidative-stress response.

Sulforaphane and Healthy Aging

Executive summary

Sulforaphane is studied in healthy-aging research because it connects to Keap1 modification, Nrf2 nuclear movement, ARE binding, antioxidant-response genes, phase II detoxification enzymes, and glutathione metabolism. Human evidence is mostly based on oxidative-stress, inflammatory, vascular, and metabolic biomarkers rather than lifespan outcomes.

Evidence

Human studies are mixed. Some trials do not show increased Nrf2 target-gene expression, while others report changes in platelet activation markers, ex vivo Nrf2 activity, NQO1, HO-1, GR, GCLC, or glutathione-related signals. Observational data link cruciferous vegetable intake with some vascular aging markers, but observational data cannot establish causality.

Dose and safety

Research forms include oral sulforaphane, precision-grown broccoli foods, and glucoraphanin-plus-myrosinase preparations. Study examples include sulforaphane 25-150 micromol/day, single servings of precision-grown broccoli foods, or higher glucoraphanin doses. Tolerability is generally good, but absorption can vary by formulation, myrosinase activity, enteric coating, acid-suppressing medication, and microbiome status.

Consumer interpretation

Sulforaphane is not a “longevity promise.” A balanced dietary-supplement interpretation is that it is studied for cellular defense, glutathione, antioxidant response, detoxification enzymes, and oxidative-stress response in healthy-aging biology.